Catheter Precision VTAK 深 滬
已收盤 10-02 16:00:00 美东时间
0.151
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.151
- 總市值 286.48万
- 52周最高 30.60
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.288
- 委 比 0.00%
- 總股本 1897.20万
- 歷史最高 52250000.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.288
- 每 手 1
- 風險率 7.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets
Proposed Sale to include VIVO and LockeT Cardiac Electrophysiology product lines Divestiture would Complete the Company's Planned Transition to Pure-Play Tech-Enabled Private Aviation The Pr...
11-05 05:15
Catheter Precision Receives FDA Clearance For Its VIVO System To Expand Labeling In Its Indications For Use Statement
Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced that its VIVO system has received FDA 510(k) clearance for expanded labeling in its Indications for Use statement. The VIVO system is now cleared for a broader patient population, specificall...
11-02 21:10
Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
Catheter Precision, a subsidiary of Flyte Aviation, Inc., announced that its VIVO system has received FDA 510(k) clearance for expanded labeling, now cleared for use in patients with structural heart disease undergoing catheter ablation for monomorphic ventricular tachycardia. The VIVO system, a non-invasive 3D imaging tool, enhances pre-procedural planning, potentially reducing procedure times and improving outcomes. This expansion marks a signi...
11-02 13:00
Flyte Aviation's Catheter Precision Publishes Comparative Study Evaluating Its LockeT Suture Retention Device Against A Traditional Internal Vascular Closure Device Following Large Bore Venous Access
Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE:VJET), today announced the first published comparative study evaluating its LockeT suture retention device against a traditional internal vascular closure device (VCD) following large bore venous access. The 172-patient peer...
10-23 05:00
Flyte Aviation revenue doubled QoQ to record $2.15M as user base surges
Flyte Aviation (VJET) Monday reported record preliminary third quarter revenue of ~$2.15M. This represents an increase of ~110%, quarter-over-quarter, compared with $1.02M in the second quarter of 202...
10-12 18:46
Flyte Aviation Rebrands and Executes Reverse Stock Split
Flyte Aviation ( ($VJET) ) has shared an update. On October 5, 2026, Flyte Avia...
10-06 05:03
Flyte Aviation Launches Under NYSE American Ticker “VJET”
Flyte Aviation, Inc. (NYSE American: VJET) aims to disrupt the $11.6 billion U.S. private jet charter market with its proprietary AI-driven platform, combining technology, data, and an expanding aviation network. The company's strategy focuses on customer acquisition, network expansion, and brand awareness to enhance shareholder value. Flyte offers privacy, comfort, reliability, and convenience at competitive prices, targeting a fragmented indust...
10-05 08:15
Catheter Precision Board Approves Rebranding To Flyte Aviation And 1-For-10 Reverse Stock Split, Effective October 5, 2026
On September 24, 2026, the Board of Directors (the "Board") of Catheter Precision, Inc. (the "Company") approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to (i) change the Company's name from "Catheter Precision, Inc." to "Flyte Aviation, Inc." (th...
09-26 05:29
Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil
Catheter Precision Inc. has expanded its LockeT product in Brazil to six hospitals since its August launch and plans to extend its reach across Latin America, including Argentina, Chile, and Colombia. The company is collaborating with an experienced cardiology group to support this regional growth. LockeT, a suture retention device, has shown strong initial traction in Brazil, providing a foundation for further international expansion. CEO David ...
09-17 12:00
Catheter Precision Announces Significant Commercial Growth Across Its LockeT And VIVO Product Lines Via New U.S. Distribution Channels, Premier Hospital Adoption And International Expansion
Key Commercial Highlights: Cardinal Health Strategic Reach: Catheter Precision received its first purchase order for LockeT via Cardinal Health. As one of the nation's largest distributors—servicing roughly 90% of U.S. hospitals—Cardinal Health provides LockeT a massive streamlined supply chain netw...
08-27 20:08
